Vertex Pharmaceuticals (VRTX) Cash from Investing Activities (2016 - 2026)
Quarterly Cash from Investing Activities fell 674.01% to -$431.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.3 billion through Mar 2026, up 21.78% year-over-year, with the annual reading at -$945.4 million for FY2025, 74.92% up from the prior year.
Vertex Pharmaceuticals' Cash from Investing Activities history spans 18 years, with the latest figure at -$431.9 million for Q1 2026.
- Cash from Investing Activities came in at -$431.9 million for Q1 2026, down from -$288.1 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $175.6 million in Q4 2022 to a low of -$2.1 billion in Q1 2024.
- The 5-year median for Cash from Investing Activities is -$348.0 million (2024), against an average of -$506.5 million.
- Year-over-year, Cash from Investing Activities soared 231.04% in 2022 and then tumbled 3495.29% in 2023.
- Vertex Pharmaceuticals' Cash from Investing Activities stood at $175.6 million in 2022, then crashed by 604.84% to -$886.5 million in 2023, then increased by 7.29% to -$821.9 million in 2024, then soared by 64.95% to -$288.1 million in 2025, then tumbled by 49.91% to -$431.9 million in 2026.
- Per Business Quant, the three most recent readings for VRTX's Cash from Investing Activities are -$431.9 million (Q1 2026), -$288.1 million (Q4 2025), and -$117.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -428.90 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | 172.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -431.90 Mn |
| Mar 31, 2026 | -431.90 Mn |
| Dec 31, 2025 | -288.10 Mn |
| Dec 31, 2025 | -288.10 Mn |
| Sep 30, 2025 | -117.00 Mn |
| Sep 30, 2025 | -117.00 Mn |
| Jun 30, 2025 | -484.50 Mn |
| Jun 30, 2025 | -484.50 Mn |
| Mar 31, 2025 | -55.80 Mn |
| Mar 31, 2025 | -55.80 Mn |
| Dec 31, 2024 | -821.90 Mn |
| Dec 31, 2024 | -821.90 Mn |
| Sep 30, 2024 | -348.00 Mn |
| Sep 30, 2024 | -348.00 Mn |
| Jun 30, 2024 | -463.70 Mn |
| Jun 30, 2024 | -463.70 Mn |
| Mar 31, 2024 | -2.14 Bn |
| Mar 31, 2024 | -2.14 Bn |
| Dec 31, 2023 | -886.50 Mn |
| Dec 31, 2023 | -886.50 Mn |
| Sep 30, 2023 | -117.70 Mn |
| Sep 30, 2023 | -117.70 Mn |
| Jun 30, 2023 | -303.90 Mn |
| Jun 30, 2023 | -303.90 Mn |
| Mar 31, 2023 | -1.83 Bn |
| Mar 31, 2023 | -1.83 Bn |
| Dec 31, 2022 | 175.60 Mn |
| Dec 31, 2022 | 175.60 Mn |
| Sep 30, 2022 | -384.20 Mn |
| Sep 30, 2022 | -384.20 Mn |
| Jun 30, 2022 | -61.50 Mn |
| Jun 30, 2022 | -61.50 Mn |
| Mar 31, 2022 | -51.00 Mn |
| Mar 31, 2022 | -51.00 Mn |
| Dec 31, 2021 | -134.00 Mn |
| Dec 31, 2021 | -134.00 Mn |
| Sep 30, 2021 | -52.90 Mn |
| Sep 30, 2021 | -52.90 Mn |
| Jun 30, 2021 | -79.70 Mn |
| Jun 30, 2021 | -79.70 Mn |
| Mar 31, 2021 | -74.30 Mn |
| Mar 31, 2021 | -74.30 Mn |
| Dec 31, 2020 | 243.76 Mn |
| Dec 31, 2020 | 243.76 Mn |
| Sep 30, 2020 | -247.94 Mn |
| Sep 30, 2020 | -247.94 Mn |
| Jun 30, 2020 | 71.91 Mn |
| Jun 30, 2020 | 71.91 Mn |
| Mar 31, 2020 | 31.67 Mn |
| Mar 31, 2020 | 31.67 Mn |
| Dec 31, 2019 | -896.97 Mn |
| Dec 31, 2019 | -896.97 Mn |
| Sep 30, 2019 | -249.00 Mn |
| Sep 30, 2019 | -249.00 Mn |
| Jun 30, 2019 | -50.19 Mn |
| Jun 30, 2019 | -50.19 Mn |
| Mar 31, 2019 | -39.14 Mn |
| Mar 31, 2019 | -39.14 Mn |
| Dec 31, 2018 | -40.90 Mn |
| Dec 31, 2018 | -40.90 Mn |
| Sep 30, 2018 | -49.89 Mn |
| Sep 30, 2018 | -49.89 Mn |
| Jun 30, 2018 | -116.30 Mn |
| Jun 30, 2018 | -116.30 Mn |
| Mar 31, 2018 | 4.93 Mn |
| Mar 31, 2018 | 4.93 Mn |
| Dec 31, 2017 | -20.79 Mn |
| Dec 31, 2017 | -20.79 Mn |
| Sep 30, 2017 | -225.28 Mn |
| Sep 30, 2017 | -225.28 Mn |
| Jun 30, 2017 | -76.28 Mn |
| Jun 30, 2017 | -76.28 Mn |
| Mar 31, 2017 | -160.98 Mn |
| Mar 31, 2017 | -160.98 Mn |
| Dec 31, 2016 | 176.94 Mn |
| Dec 31, 2016 | 176.94 Mn |
| Sep 30, 2016 | 34.79 Mn |
| Sep 30, 2016 | 34.79 Mn |
| Jun 30, 2016 | -57.78 Mn |
| Jun 30, 2016 | -57.78 Mn |